Dermapharm
DMP.F
$33.88
Share price
2.26%
Change (1 day)
-31.42%
Change (1 year)
Operating Margin for Dermapharm (DMP.F)
Operating Margin as of April 2024 (TTM): 22.74%
According to Dermapharm's latest financial reports and stock price the company's current Operating Margin is 22.74%. At the end of 2021 the company had an Operating Margin of 31.07%.
Operating Margin history for Dermapharm from 2017 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 31.07% | 96.88% |
| 2020 | 15.78% | 0.5% |
| 2019 | 15.70% | -13.76% |
| 2018 | 18.21% | -3.37% |
| 2017 | 18.85% | 1.08% |
| 2016 | 18.64% | 29.75% |
| 2015 | 14.37% | 58.46% |
| 2014 | 9.07% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.